Scotiabank Forecasts Strong Price Appreciation for Exact Sciences (NASDAQ:EXAS) Stock
Exact Sciences (NASDAQ:EXAS – Free Report) had its target price lifted by Scotiabank from $70.00 to $73.00 in a research note released on Monday,Benzinga reports. The brokerage currently has a sector outperform rating on the medical research company’s stock. Other research analysts have also recently issued reports about the stock. Sanford C. Bernstein boosted their […]
Exact Sciences (NASDAQ:EXAS – Free Report) had its target price lifted by Scotiabank from $70.00 to $73.00 in a research note released on Monday,Benzinga reports. The brokerage currently has a sector outperform rating on the medical research company’s stock. Other research analysts have also recently issued reports about the stock. Sanford C. Bernstein boosted their […]
